Astex Pharmaceuticals, Inc 4

Accession 0001179110-13-015573

CIK 0000919722operating

View on SEC.gov Company Profile

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 7:33 PM ET

Size

44.3 KB

Accession

0001179110-13-015573

Insider Transaction Report

Form 4

Period: 2013-10-11

Astex Pharmaceuticals, IncASTX

Goldberg Allan R

Director

Transactions

Disposition to Issuer
Director Stock Option (Right to buy)
2013-10-11−7,500→ 0 total
Exercise: $4.84Exp: 2015-05-12→ Common Stock (7,500 underlying)
Disposition to Issuer
Director Stock Option (Right to buy)
2013-10-11−833→ 0 total
Exercise: $2.92From: 2011-06-16Exp: 2021-06-16→ Common Stock (833 underlying)
Disposition to Issuer
Director Stock Option (Right to buy)
2013-10-11−12,658→ 0 total
Exercise: $1.89Exp: 2018-07-28→ Common Stock (12,658 underlying)
Disposition to Issuer
Director Stock Option (Right to buy)
2013-10-11−8,889→ 0 total
Exercise: $3.65Exp: 2016-07-26→ Common Stock (8,889 underlying)
Disposition to Issuer
Director Stock Option (Right to buy)
2013-10-11−10,204→ 0 total
Exercise: $2.70Exp: 2019-07-28→ Common Stock (10,204 underlying)
Disposition to Issuer
Director Stock Option (Right to buy)
2013-10-11−15,267→ 0 total
Exercise: $1.94Exp: 2020-07-26→ Common Stock (15,267 underlying)
Disposition to Issuer
Director Stock Option (Right to buy)
2013-10-11−20,000→ 0 total
Exercise: $2.10Exp: 2022-06-22→ Common Stock (20,000 underlying)
Disposition to Issuer
Director Stock Option (Right to buy)
2013-10-11−50,000→ 0 total
Exercise: $4.89Exp: 2015-03-04→ Common Stock (50,000 underlying)
Disposition to Issuer
Director Stock Option (Right to buy)
2013-10-11−10,000→ 0 total
Exercise: $3.97Exp: 2016-06-09→ Common Stock (10,000 underlying)
Disposition to Issuer
Director Stock Option (Right to buy)
2013-10-11−8,621→ 0 total
Exercise: $4.03Exp: 2017-09-17→ Common Stock (8,621 underlying)
Disposition to Issuer
Director Stock Option (Right to buy)
2013-10-11−25,000→ 0 total
Exercise: $2.14Exp: 2020-06-10→ Common Stock (25,000 underlying)
Disposition to Issuer
Director Stock Option (Right to buy)
2013-10-11−15,000→ 0 total
Exercise: $2.92Exp: 2021-06-16→ Common Stock (15,000 underlying)

Footnotes (33)

[F1]The option provided for vesting as to 20% of the shares on March 4, 2005 and each one year anniversary thereafter.
[F10]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $26,100.00, which represents the difference between $8.50 and the exercise price of the option per share.
[F11]The option provided for vesting as to as to 1/12th of the shares on August 26, 2007 and on each one month anniversary thereafter.
[F12]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $38,535.87, which represents the difference between $8.50 and the exercise price of the option per share.
[F13]The option provided for vesting as to 1/4th of the shares on June 12, 2008 and on each three month anniversary thereafter.
[F14]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $64,900.00, which represents the difference between $8.50 and the exercise price of the option per share.
[F15]The option provided for vesting as to as to 1/12th of the shares on August 28, 2008 and on each one month anniversary thereafter.
[F16]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $83,669.38 which represents the difference between $8.50 and the exercise price of the option per share.
[F17]The option provided for vesting as to 1/4th of the shares on June 11, 2009 and on each three month anniversary thereafter.
[F18]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $65,200.00, which represents the difference between $8.50 and the exercise price of the option per share.
[F19]The option provided for vesting as to as to 1/12th of the shares on August 28, 2009 and on each one month anniversary thereafter.
[F2]Pursuant to the Agreement and Plan of Merger, dated September 5, 2013, between the Issuer, Otsuka Pharmaceutical Co., Ltd., and Autumn Acquisition Corporation (the "Merger Agreement"), the option was cancelled in exchange for a cash payment of $180,500.00, which represents the difference between $8.50 and the exercise price of the option per share.
[F20]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $59,183.20, which represents the difference between $8.50 and the exercise price of the option per share.
[F21]The option provided for vesting as to 1/4th of the shares on September 17, 2009 and on each three month anniversary thereafter.
[F22]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $39,300.00, which represents the difference between $8.50 and the exercise price of the option per share.
[F23]The option provided for vesting as to 1/4th of the shares on June 10, 2010 and on each three month anniversary thereafter.
[F24]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $159,000.00, which represents the difference between $8.50 and the exercise price of the option per share.
[F25]The option provided for vesting as to as to 1/12th of the shares on August 26, 2010 and on each one month anniversary thereafter.
[F26]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $100,151.52, which represents the difference between $8.50 and the exercise price of the option per share.
[F27]The option provided for vesting as to 1/4th of the shares on June 16, 2011 and on each three month anniversary thereafter.
[F28]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $83,700.00, which represents the difference between $8.50 and the exercise price of the option per share.
[F29]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $4,648.14, which represents the difference between $8.50 and the exercise price of the option per share.
[F3]The option provided for vesting as to 1/4th of the shares on May 12, 2005 and on each three month anniversary thereafter.
[F30]The option provided for vesting as to 1/4th of the shares on June 22, 2012 and on each three month anniversary thereafter.
[F31]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $128,000.00, which represents the difference between $8.50 and the exercise price of the option per share.
[F32]The option originally provided for vesting as to 1/4th of the shares on June 13, 2013 and on each three month anniversary thereafter. Pursuant to the Merger Agreement, the option vested in full immediately prior to the closing of the merger.
[F33]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $78,000.00, which represents the difference between $8.50 and the exercise price of the option per share.
[F4]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $27,450.00, which represents the difference between $8.50 and the exercise price of the option per share.
[F5]The option provided for vesting as to 1/4th of the shares on June 9, 2006 and on each three month anniversary thereafter.
[F6]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $45,300.00, which represents the difference between $8.50 and the exercise price of the option per share.
[F7]The option provided for vesting as to 1/12th of the shares on August 26, 2006 and on each one month anniversary thereafter.
[F8]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $43,111.65, which represents the difference between $8.50 and the exercise price of the option per share.
[F9]The option provided for vesting as to 1/4th of the shares on June 14, 2007 and on each three month anniversary thereafter.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

Astex Pharmaceuticals, Inc

CIK 0000919722

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0000919722

Filing Metadata

Form type: 4
Filed: Oct 15, 8:00 PM ET
Accepted: Oct 16, 7:33 PM ET
Size: 44.3 KB

View on SEC.gov